
Bharat Immunological Hits New Low Amid Sustained Bearish Trend in Pharmaceuticals Sector
2025-02-17 09:40:49Bharat Immunological & Biological Corporation has reached a new 52-week low, continuing a downward trend with a notable decline over the past year. The company is trading below all key moving averages, indicating persistent challenges in the microcap pharmaceuticals sector, contrasting sharply with broader market performance.
Read More
Bharat Immunological Hits 52-Week Low Amid Broader Market Challenges in October 2023
2025-02-14 15:05:21Bharat Immunological & Biological Corporation has reached a new 52-week low, continuing a downward trend over the past two days. Despite outperforming its sector, the company has seen a significant decline over the past year, contrasting with broader market gains. Its stock is trading below key moving averages.
Read More
Bharat Immunological Hits 52-Week Low Amid Ongoing Downward Trend in Pharmaceuticals Sector
2025-02-12 10:07:02Bharat Immunological & Biological Corporation has reached a new 52-week low, continuing a six-day decline totaling 14.44%. The stock's one-year performance is down 35.14%, contrasting with the Sensex's gain. Currently, it trades below multiple moving averages, indicating a persistent bearish trend in the pharmaceuticals sector.
Read More
Bharat Immunological Hits 52-Week Low Amid Sector-Wide Decline in Pharmaceuticals
2025-02-11 13:35:51Bharat Immunological & Biological Corporation has reached a new 52-week low, reflecting ongoing challenges in the pharmaceuticals sector. The company has faced consecutive losses over the past week and is trading below multiple moving averages, indicating a sustained downward trend amid a broader sector decline.
Read More
Bharat Immunological Hits 52-Week Low Amid Sector-Wide Decline in Pharmaceuticals
2025-02-11 13:35:51Bharat Immunological & Biological Corporation has reached a new 52-week low, reflecting ongoing challenges in the pharmaceuticals sector. The company has faced consecutive losses over the past week and is trading below multiple moving averages, indicating a sustained downward trend amid a broader sector decline.
Read More
Bharat Immunological Hits 52-Week Low Amid Sector-Wide Decline in Pharmaceuticals
2025-02-11 13:35:51Bharat Immunological & Biological Corporation has reached a new 52-week low, reflecting ongoing challenges in the pharmaceuticals sector. The company has faced consecutive losses over the past week and is trading below multiple moving averages, indicating a sustained downward trend amid a broader sector decline.
Read More
Bharat Immunological Hits 52-Week Low Amid Sector-Wide Decline in Pharmaceuticals
2025-02-11 13:35:51Bharat Immunological & Biological Corporation has reached a new 52-week low, reflecting ongoing challenges in the pharmaceuticals sector. The company has faced consecutive losses over the past week and is trading below multiple moving averages, indicating a sustained downward trend amid a broader sector decline.
Read More
Bharat Immunological Hits 52-Week Low Amid Sector-Wide Decline in Pharmaceuticals
2025-02-11 13:35:51Bharat Immunological & Biological Corporation has reached a new 52-week low, reflecting ongoing challenges in the pharmaceuticals sector. The company has faced consecutive losses over the past week and is trading below multiple moving averages, indicating a sustained downward trend amid a broader sector decline.
Read MoreBoard Meeting Intimation for Intimation Of Date Of Board Meeting On 16.08.2024 Under Regulation 29 Of SEBIS LODR.
07-Aug-2024 | Source : BSEBHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/08/2024 inter alia to consider and approve Pursuant to the Regulation 29 and other applicable Regulation(s) of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations 2015 it is informed that a meeting of the Board of Directors of the Company is scheduled to be held on Friday 16th August 2024 for General Purpose.
Board Meeting Intimation for Intimation Of Date Of Board Meeting On 08.03.2024 Under Regulation 29 Of SEBIS LODR.
29-Feb-2024 | Source : BSEBHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/03/2024 inter alia to consider and approve Pursuant to the Regulation 29 and other applicable Regulation(s) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 it is informed that a meeting of the Board of Directors of the Company is scheduled to be held on Friday 08th March 2024 for General Purpose.
Compliance Of Regulation 34 Of LODR 2015 And Submission Annual Report For 34Th Annual General Meeting Scheduled On 29.12.2023.
13-Dec-2023 | Source : BSESubmission of Draft Annual Report 2022-23 for AGM on 29.12.2023
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available